Clinical Trials Logo

Filter by:
NCT ID: NCT01744275 Suspended - Epilepsy Clinical Trials

HOPE-Epilepsy Trial

HOPE-Epilepsy
Start date: July 2013
Phase: Phase 2/Phase 3
Study type: Interventional

This a multi-center study to examine whether supplementation with omega 3 fatty acids will reduce seizure frequency in patients with epilepsy .

NCT ID: NCT01666249 Suspended - Clinical trials for Pregnancy; Fetomaternal Hemorrhage

Clinical Efficacy of Postpartum Immunization of Rh and Coombs Negative Women With Sensitization Risk.

Start date: April 2014
Phase: Phase 3
Study type: Interventional

This a open, prospective, multicenter, single-arm, phase III study for clinical assessment of anti-Rh immunoglobulin (KamRho-D®) in Rh and Coombs negative women with risk sensitization. The anti-Rh immunoglobulin is an immunobiological containing high concentration of specific antibodies against factor D and "neutralizes" D antigen present in the Rh-positive fetal red blood cells (Rh +), which passed into the bloodstream of Rh-negative pregnant women (Rh).

NCT ID: NCT01620788 Suspended - Hypertension Clinical Trials

Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

Start date: November 27, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the clinical efficacy of indapamide 1.5mg / losartan 50mg and indapamide 1.5mg / losartan 100mg on reduction of blood pressure.

NCT ID: NCT01496768 Suspended - Clinical trials for Effect of Chronic Leucine Supplementation on Glucose Homeostasis, Lipid Profile, Body Composition, and Muscle Mass and Strenght

Effects of Chronic Leucine Supplemetion on Glucose Homeostasis, Body Compositin, Muscle Mass and Strength of Healthy and Young Subjects

Start date: January 2012
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of chronic leucine supplemetion on glucose homeostasis, body compositin, muscle mass and strength of healthy and young subjects

NCT ID: NCT01305018 Suspended - Inflammation Clinical Trials

Branched-chain Amino Acids Supplementation and Resistance Exercise-induced Muscle Damage and Inflammation

Start date: August 2011
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of branched-chain amino acids (BCAA) supplementation on resistance exercise-induced muscle damage and inflammation.

NCT ID: NCT01244256 Suspended - Folliculitis Clinical Trials

Efficacy and Comparative of the Association Beclomethasone Clotrimzaol + Gentamicin in Patients With Acne Contaminated

acne
Start date: April 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this trial is to evaluate the comparative efficacy of the combination of Clotrimazole + Gentamicin + Beclomethasone in study subjects with a condition of contaminated dermatosis showing bilateral symmetrical lesions.

NCT ID: NCT01229072 Suspended - Clinical trials for Chronic Renal Failure

Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.

Heparin
Start date: July 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The Heparin form a complex with a plasma protein, antithrombin III (ATIII), which is an endogenous anticoagulant. This complex inhibits the formation of thrombin and accelerates its destruction. Moreover, heparin and other proteases ATIII inactivate the clotting cascade, especially the anti-activated factor X. The end result of these actions is the inhibition of biochemical training and synthesis of certain clotting factors that activators of critical functions in the genesis of a blood clot. Patients with chronic renal failure (CRF) who use the treatment of hemodialysis need a system of anticoagulation with the direct thrombin inhibitor and / or heparinóides to prevent thrombosis. Based on clinical studies, to control the level of plasma heparin in patients with CRF is essential. Evidence of clotting as APTT, TP, ACT and proof of the activity of anti-factor Xa should be used as a substrate of protection for those patients on hemodialysis.

NCT ID: NCT01151176 Suspended - Clinical trials for Acute Coronary Syndrome

Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome

Start date: August 2012
Phase: Phase 4
Study type: Interventional

The study aims to demonstrate that a simple intravenous insulin algorithm can be implemented in Latin America and will result in safe and better glucose control in patients with Acute Coronary Syndrome (ACS) compared with SC insulin.

NCT ID: NCT01086982 Suspended - Acromegaly Clinical Trials

Pharmacodynamics Of Product Octreotide Acetate Lar 30 Mg Compared To Product Sandostatin LAR ®

Start date: March 2010
Phase: Phase 1
Study type: Interventional

Check the pharmacodynamics of the drug octreotide acetate LAR 30 mg imported and distributed by Chemical Laboratory Pharmaceutical Bergamo Ltda. compared to the drug Sandostatin LAR ® (octreotide acetate 30 mg) manufactured by Novartis Biociências S / A, using as activity analysis of growth hormone (GH) and growth factor insulin-like 1 (IGF-1 ) after a single dose of the drug in patients with acromegaly

NCT ID: NCT00994630 Suspended - Clinical trials for Bipolar Disease Type I

Biomarkers for Bipolar Disorder: Chaperones and Reticulum Endoplasmatic Stress Response CHAP´s Study

CHAPS
Start date: January 2010
Phase: N/A
Study type: Observational

The purpose of this study is to determine expression of chaperones proteins from the endoplasmatic reticulum stress response system in bipolar I patients (manic phase) compared to healthy controls. Hypothesis: There is no difference in chaperones proteins expression between bipolar I manic patients and healthy controls